BUTTERFLY NETWORK INC CLASS A (BFLY)
Health Care · medical devices / diagnostic imaging · NYSE
Butterfly Network provides portable, semiconductor-based ultrasound technology to make medical imaging more accessible and affordable globally.
What BUTTERFLY NETWORK INC CLASS A does
Butterfly Network is a digital health company focused on transforming medical imaging through its proprietary ultrasound-on-a-chip technology. The company develops and markets handheld, portable ultrasound devices and software platforms that integrate with mobile devices to provide diagnostic imaging capabilities.
Themes: point-of-care ultrasound, digital health, medical imaging hardware, mobile medical technology
Fundamentals
- Price$8.95 as of 2026-08-24 close
- Market cap$2.6B as of 2026-08-24
- 1-year return+488.8% 2025-08-22 close $1.52 → 2026-08-24 close $8.95
- P/En/a negative earnings
- Net margin-66.8% as of 2026-08-24
- Gross margin+52.6% as of 2026-08-24
- ROE-38.4% as of 2026-08-24
- Debt / equity0.00 as of 2026-08-24
- Revenue growth (YoY)+28.1% as of 2026-08-24
- Revenue CAGR (3y)+10.0% SEC XBRL
- Beta2.49 as of 2026-08-24
- Last reported earnings2026-07-30 SEC EDGAR Form 8-K (Item 2.02)
How BFLY compares in its sector
- net profit marginmiddle range 504 covered Health Care peers, as of 2026-08-24
- operating marginmiddle range 504 covered Health Care peers, as of 2026-08-24
- gross marginmiddle range 384 covered Health Care peers, as of 2026-08-24
- return on equitymiddle range 576 covered Health Care peers, as of 2026-08-24
- 3-year revenue CAGRmiddle range 402 covered Health Care peers
- free cash flow (absolute dollars, latest fiscal year)middle range 493 covered Health Care peers, as of FY2025
Position among covered Health Care companies that report each metric (minimum 5 peers). A relative position within our covered catalog — not a valuation, quality, or investment judgment. A higher percentile is simply a higher value (for P/E, more expensive on earnings — never "better"). Informational only.
Top 10 scores & list membership
BFLY is not currently in any published Top 10 list. Its scores are below.
Long-term score
55.5 #483 of 1,605 scored · #58 of 195 in Health Care
Financial health 95th (debt to equity 0) and long-term trend 86th (trading above its 200-day average); weakest is profitability (5th, operating margin -70.8%, return on equity -38.4%).
Short-term score
62.2 #122 of 1,698 scored · #33 of 236 in Health Care
Trend 82nd: a strong uptrend, with buyers in control; momentum 72nd: over the past 3 months this stock beat the market by 97.8 percentage points; weakest is catalysts 45th: analysts' average price target is unchanged from the prior reading. Its short interest was not measured, so no short-interest deduction applies.
Scores as of 24 Aug 2026. Each bar is a percentile: how this company ranked against every company the score ranked, 0–100. A list is a published formula and its output, not a recommendation. Method version 3.
How BUTTERFLY NETWORK INC CLASS A looks technically
BUTTERFLY NETWORK INC CLASS A (BFLY) is trading 83.8% above its 200-day average, the long-term trend line — a longer-term uptrend. Its 50-day average crossed above its 200-day average about 184 trading days ago — a "golden cross", a bullish long-term signal. A strong uptrend is in place — ADX, a 0–100 trend-strength gauge, is 41, with buyers in control. Momentum is neutral — its 14-day RSI (a 0–100 momentum gauge) is 55, neither overbought (above 70) nor oversold (below 30). MACD, a trend-momentum gauge, turned bearish about 1 trading day ago (its momentum flipped negative). It made a new 20-day high about 11 trading days ago.
Trend
8
| Distance from the 200-day | it is trading 83.8% above its 200-day average, the long-term trend line — a longer-term uptrend | +83.8% |
|---|---|---|
| 50-day moving average | its average price over the last 50 trading days — a short-term trend line — is $7.85 | $7.85 |
| 200-day moving average | its average price over the last 200 trading days — the long-term trend line — is $4.87 | $4.87 |
| Swing structure | each recent peak has been higher than the one before it and each dip has been shallower — the pattern chart-watchers call an uptrend, which describes where price has already been and not where it goes next | higher highs and higher lows |
| Last swing turn | its last significant turn was a swing high 14 calendar days ago — the swings before that are what the structure reading is measured on | 14 sessions |
| Wave structure | its recent swings can be read as a five-part upward sequence — what Elliott-wave chartists call an impulse — now in the fourth leg, a pullback against that upward direction; the labelling fails if price closes below 4.7. It is one of several labellings that fit, and it describes the swings already printed, not what comes next. The same swings also read as a completed three-part correction. | possible upward five-wave sequence, in wave 4 (one of several readings) |
| Since the 50/200 cross | its 50-day average crossed above its 200-day average about 184 trading days ago — a "golden cross", a bullish long-term signal | 184 sessions |
| Trend strength (14-day ADX) | a strong uptrend is in place — ADX, a 0–100 trend-strength gauge, is 41, with buyers in control | 40.9 |
Momentum
3
| 14-day RSI | momentum is neutral — its 14-day RSI (a 0–100 momentum gauge) is 55, neither overbought (above 70) nor oversold (below 30) | 55.4 |
|---|---|---|
| Position in its 14-day range | it is trading in the lower half of its 14-day range ($8.22 to $10.05) — its "stochastic" reading is 40 out of 100, where 0 would mean closing exactly at the 14-session low and 100 exactly at the high. This measures WHERE the price sits inside its recent range, which is a different question from the RSI beside it: RSI is a momentum gauge, measuring how FAST the price has been moving, so a stock can drift quietly to the bottom of its range with an ordinary RSI, or fall sharply and still sit in the middle. It has been slipping within that range over the last few sessions. | 39.9 |
| Since the MACD crossed zero | MACD, a trend-momentum gauge, turned bearish about 1 trading day ago (its momentum flipped negative) | 1 session |
Range
12
| 52-week high | its highest closing price over the past year (about 252 trading days) was $10.05 | $10.05 |
|---|---|---|
| From the 52-week high | it is 10.9% below its 52-week high (its highest price of the past year) | -10.9% |
| Above the 52-week low | it is 553.3% above its 52-week low (its lowest price of the past year) | +553.3% |
| Below the 52-week high | it is 10.9% below its highest point of the past year | 10.9% |
| Since a 20-day breakout | it made a new 20-day high about 11 trading days ago | 11 sessions |
| Since a 55-day breakout | it made a new 55-day high about 11 trading days ago | 11 sessions |
| All-time high | its highest closing price on record is $29.13 (set on 2021-02-18) | $29.13 |
| Given back of the 52-week move | over the past year its closes ranged ($1.39 to $9.70), and it has given back only a small part of its rise from last year’s low — 9% of it. Chart-watchers call 61.8%-65% given back the "golden pocket" — for this company that is $4.30 to $4.56. It is watched widely enough that orders cluster there, which is the honest reason it matters; it is not a forecast. | 9.0% |
| From the all-time high | it is 69.3% below its all-time high | -69.3% |
| Nearest price level | it is trading 44.3% above a support level at $4.99 — a price it turned at three times since 2025-02-18, most recently on 2026-02-26. Since 2024-08-26 it has 17 such levels below the current price and 0 above. Levels like these describe where the price has reversed or paused before; they are not a forecast of where it will go. | -44.3% |
| All-time low | its lowest closing price on record is $0.674 (set on 2024-04-25) | $0.674 |
| Above the all-time low | it is 1227.9% above its all-time low | +1,228% |
Volatility
5
| Band width vs its own 6 months | day-to-day price swings are narrower than usual versus its own recent 6-month history (tighter than about 71% of it) | 29th percentile |
|---|---|---|
| Typical daily range | in a typical session it travels about $0.6763 between its high and its low — about 7.6% of its price. That is its "average true range" over the last 14 sessions, which also counts the distance from the previous close, so a day that opens well away from yesterday counts as the large move it was | $0.6763 |
| Bollinger bands (20-day, ±2σ) | most of its recent trading has stayed between about $7.13 and $10.19 — the "Bollinger bands", a range drawn two standard deviations either side of its 20-day average price, which widens when the stock gets more volatile and narrows when it settles | $7.13 – $8.66 – $10.19 |
| Typical daily range (% of price) | its price moves about 7.6% in a typical session — more volatile than most companies we cover. This is the average gap between a session's high and low over the last 14 sessions, counting overnight moves, expressed against the current price so it can be compared with companies trading at any price | 7.6% |
| Stretch from the 200-day average | it is trading 6.0 daily ranges above its 200-day average price (83.8% above it in plain percentage terms) — a way of asking how far it has stretched from its own average in units of how far it normally moves in a day, so a calm company and a jumpy one can be compared on the same scale | 6.0 daily ranges above its 200-day average |
Volume
1
| Volume vs its 30-day average | trading volume is about normal versus its 30-day average | 0.66× |
|---|
Analyst
2
| Change in the average price target | analysts' average price target is unchanged from the prior reading | 0.0% |
|---|---|---|
| Change in the consensus rating | the analyst consensus rating is unchanged since the prior reading | unchanged |
Candlestick patterns
1
| Since a doji | 4 sessions ago it opened and closed at almost the same price after trading through a wider range — a "doji", the classic picture of buyers and sellers finishing the session level | 4 sessions ago |
|---|
Price gaps
3
| Gap at the open | it opened on 2026-08-24 1.3% below the previous session's close — an overnight gap, the part of the move that happened while the market was shut, and had not traded back through that level by the close | -1.3% |
|---|---|---|
| Open gap | it gapped 3.0% above the previous close 11 sessions ago and has not traded back through the level it left behind at 8.3 — an "unfilled gap", which describes a price range no trade has since crossed and is not a forecast that it will be crossed | +3.0% |
| Gap filled | a 2.4% gap down opened on 2026-08-14 has been "filled" 6 sessions ago — price traded back through the level the gap left behind, and it closed again during the very session that opened it | 6 sessions ago |
Price streaks
1
| Closing streak | it closed lower in its latest session, after a session that did not close lower — a single down day rather than a run | 1 session down |
|---|
Relative strength
4
| vs market, 1 month | over the past 1 month this stock beat the market by 31.8 percentage points (the stock gained 35.2% while the market gained 3.4%) | +31.8% |
|---|---|---|
| vs market, 3 months | over the past 3 months this stock beat the market by 97.8 percentage points (the stock gained 100.2% while the market gained 2.4%) | +97.8% |
| vs market, 6 months | over the past 6 months this stock beat the market by 192.3 percentage points (the stock gained 203.4% while the market gained 11.1%) | +192.3% |
| vs market, 12 months | over the past 12 months this stock beat the market by 470.5 percentage points (the stock gained 488.8% while the market gained 18.3%) | +470.5% |
Signal agreement
2
| Bullish technical signals | 5 of the 9 technical signals we can compute for it are currently in a bullish state: a strong uptrend, with buyers in control, a "golden cross" — its 50-day average is above its 200-day, trading above its 200-day average, outperforming the market over 6 months, trading above the Ichimoku cloud — these describe past price behaviour, not a forecast | 5 of 9 |
|---|---|---|
| Bearish technical signals | 1 of the 9 technical signals we can compute for it is currently in a bearish state: MACD momentum is negative — these describe past price behaviour, not a forecast | 1 of 9 |
Trend (Ichimoku cloud)
1
| Vs the Ichimoku cloud | trading 17% above the Ichimoku cloud — a band drawn from where its own highs and lows sat up to 2026-07-16 and projected forward over today's price, the side traders read as an established uptrend, with the band below acting as the level that would have to give way. The band itself is thick, spanning 10.0% of the share price, which is taken to mean a barrier that has held for a while and takes effort to cross. | +17.5% |
|---|
Volume-weighted price
2
| Vs this year’s average price paid | the price is 52% above the average price paid so far this year, so the typical buyer over that stretch is showing a gain. That average is $5.88 — a volume-weighted average of daily closes over 160 sessions, not a true tick-by-tick VWAP. | +52.2% |
|---|---|---|
| Vs the average paid since it last reported | the price is 3% above the average price paid since it last reported on 2026-07-30 (its 10-Q), so the typical buyer over that stretch is showing a gain. That average is $8.72 — a volume-weighted average of daily closes over 18 sessions, not a true tick-by-tick VWAP. | +2.7% |
Price levels it has turned at before
BFLY last closed at $8.95 on 2026-08-24. Since 2024-08-26 it has turned at 17 prices below its last close and 0 above; the 3 nearest below are listed, nearest first.
| Level | Side | Distance | Evidence |
|---|---|---|---|
| $4.99 | Support | 44.3% below the last close | turned there three times · 2025-02-18 to 2026-02-26 |
| $4.43 | Support | 50.5% below the last close | turned there twice · 2025-01-03 to 2026-03-25 |
| $4.00 | Support | 55.3% below the last close | turned there twice · 2025-12-23 to 2026-01-20 |
A level is a price this company reversed or paused at more than once — they describe past behaviour, not a forecast of where the price will go.
Wave structure
Its recent swings can be read as a five-part upward sequence — what Elliott-wave chartists call an impulse — now in leg 4 of five, a pullback against that direction.
This labelling fails — stops being a possible reading at all — if it closes below $4.70.
This is one of several labellings that fit the same swings, so treat it as a reading rather than the reading. It was chosen from 2 labellings that survived the rules, counting shorter readings of the same bars.
On past moves of this shape the leg has usually ended somewhere between $7.20 and $8.70 — that is where it has tended to end if the count holds, not a forecast of where the price goes.
Alternate reading: The same swings also read as a completed three-part correction, which fails on a close above $10.05.
This labelling was already in place when we began recording count changes on 2026-08-13, so how long it has stood is not something we can say yet.
Read from daily closes as of 2026-08-24.
An Elliott-wave count describes the swings already printed and the level that would disprove it. It is not a forecast, a target, or advice.
Screens: Trading above the 200-day moving average · MACD just crossed bearish (12/26/9) · in a strong, established uptrend (ADX) · beating the market · Most volatile (6%+ typical daily range) · Stretched far above its 200-day average (6+ daily ranges) | Learn: moving average · golden cross · adx · rsi · macd · breakout
Based on daily closing prices as of 2026-08-24. Describes past price behavior only — informational, not financial advice.
Analyst consensus
- Consensus ratingStrong Buy (1.00 mean, 1=Strong Buy…5=Strong Sell) — 4 analysts
- Mean price target$9.31 range $5.25 – $11.00; median $10.50
Analyst estimates, as of 2026-08-18. These are third-party analyst opinions and price targets, aggregated — not a recommendation, prediction, or advice from stocks-llm. Informational only.
Analyst EPS estimate for BFLY
- Consensus EPS estimate-$0.03 next reporting period, as of 2026-08-18
Change over time is not available yet: it needs two readings of the same reporting period at least 30 days apart, and we have been recording these estimates since 2026-08-04. An estimate for a DIFFERENT quarter is not a revision, so a reading from before the last report is never compared with one after it.
The consensus estimate for the next reporting period, and how it has moved between readings of that SAME period. A change is measured only between readings estimating one period — when a company reports, the consensus moves to the next quarter and the two numbers are not comparable. Informational only, not a forecast and not advice.
Key risks (from latest filing)
["Ongoing operating losses and the need to manage growth effectively in a competitive market.","Reliance on third-party manufacturing, licensing, and supply agreements.","Dependence on regulatory authorizations and evolving medical reimbursement policies."]
What changed in the latest 10-Q
AI-assisted comparison of BFLY's 10-Q filed 2026-04-30 against the prior one filed 2025-10-31.
Management's Discussion & Analysis (MD&A)
- Added:
- Added reference to 2025 Annual Report on Form 10-K (newer filing) vs 2024 Annual Report on Form 10-K (older filing)
- Added mention of licensing proprietary Ultrasound-on-Chip™ semiconductor platform through Embedded program in Overview section
- Added specific comparison period: three months ended March 31, 2026 vs March 31, 2025 (newer) vs three months ended September 30, 2025 vs September 30, 2024 (older)
- Added detail about iQ3 Vet probe launch in United States and international markets in Q4 2025
- Added breakdown of software and other services revenue to include Embedded partnerships services, implementation and integration services, and SDKs
- Added detail that Embedded partnerships include out-licensing arrangements and related research and development services
- Added information about revenue recognition methods for services related to Embedded partnerships and implementation and integration services
- Added mention of royalty fees for licensed intellectual property in Cost of product revenue section
- Removed:
- Removed statement about cost reduction actions taken since 2022 reducing annual cash requirements by approximately $180 million to less than $50 million annually
- Removed reference to January 31, 2025 public offering of 27.6 million shares generating $81.0 million net proceeds
- Removed reference to 'Product support and maintenance (Support)' as a separate software and services offering category
- Removed reference to 'partnership support services' as a software and services offering
- Removed explanation that software and other services mix decrease was 'due in part to the continued success of our next-generation iQ3 probe and the delivery of semiconductor chips to one of our partners'
- Removed phrase 'product costs including' and changed to 'includes' in Cost of product revenue definition
- Reworded:
- Changed 'software and other related services, consisting primarily of' to 'software subscriptions and other related services, consisting primarily of' in Software and other services mix definition
- Changed 'Product revenue consists of revenue from the sale of products' to clarify structure and consolidated descriptions in Revenue section
- Restructured Revenue section to separate Product revenue from Software and other services revenue with more detailed categorization
- Changed 'Revenue consists of revenue from the sale of products... and the sale of software and other services' to 'Product revenue consists of revenue from the sale of products' with subsection breakdown
- Changed units fulfilled increase from 'driven by higher probe sales volume in our US sales channels' (Q3 2025) to 'driven by higher probe sales volume in our international distributor and veterinary sales channels' (Q1 2026)
- Changed software mix increase from -1.9 percentage points to 32.3% to +11.5 percentage points to 44.8%
- Replaced statement about decrease in software mix with statement about increase in software mix
- Notes:
- The older filing text appears truncated at end of Research and development section; comparison limited to available text
- The newer filing text also appears truncated at end of Research and development section; full section not available for comparison
- Different reporting periods compared (Q1 2026 vs prior Q3 2025 and Q3 2024 vs prior Q3 2024) make some comparisons period-specific rather than definitional
Risk Factors
- Added:
- Removed reference to 'the success, cost and timing of our efforts to out-license our intellectual property to third parties' from forward-looking statements list (in newer filing filed 2026-04-30)
- Removed reference to 'the ability to maintain the listing of our Class A common stock on the New York Stock Exchange' from risk factors (in newer filing filed 2026-04-30)
- Removed reference to 'including the imposition of tariffs' from economic downturns risk factor (in newer filing filed 2026-04-30)
- Removed:
- Reference to 'Annual Report on Form 10-K for the year ended December 31, 2024' changed to 'year ended December 31, 2025' (older filing filed 2025-10-31 referenced 2024 annual report; newer filing filed 2026-04-30 references 2025 annual report)
- Removed phrase 'we undertake no obligations' and replaced with 'We undertake no obligation' (grammatical change from plural to singular in newer filing filed 2026-04-30)
- Reworded:
- Balance sheet comparative dates changed from 'September 30, 2025 and December 31, 2024' to 'March 31, 2026 and December 31, 2025' (reflecting different quarterly reporting periods)
- Allowance description changed from 'allowance for doubtful accounts' to 'allowance for credit losses' in accounts receivable line item (newer filing filed 2026-04-30)
- Forward-looking statements list item changed from 'the pricing of our products and services, and reimbursement for medical procedures conducted using our products and services' to 'the pricing of our products and services, and reimbursement for medical procedures conducted using our medical products and services' (added 'medical' before 'products and services' in newer filing filed 2026-04-30)
- Table of contents page references changed: 'Risk Factors' moved from page 28 to page 26; 'Unregistered Sales' moved from page 28 to page 26; 'Other Information' moved from page 29 to page 26; 'Exhibits' moved from page 29 to page 26; 'Signatures' moved from page 32 to page 28 (newer filing filed 2026-04-30)
- Notes:
- The newer filing text appears truncated at the end of the operations statement, limiting complete comparison of financial statements
- Comparison is limited to the section provided; full Risk Factors section (Item 1A Part II) was not included in either filing excerpt
AI-assisted comparison of two SEC filing sections. It describes wording and theme changes only, makes no materiality, legal, or investment judgement, and is not financial advice. Informational only — not financial advice.
Insider activity (SEC Form 4)
1 open-market purchase and 31 open-market sales by insiders in the last 90 days.
- Last 30 days1 buy ($999510) · 10 sells ($36M) — 1 buying, 4 selling insiders
- Last 90 days1 buy ($999510) · 31 sells ($97M) — 1 buying, 8 selling insiders
- Last 180 days1 buy ($999510) · 34 sells ($99M) — 1 buying, 8 selling insiders
Activity heuristic: net selling (a transparent product heuristic from the counts above, not a prediction or advice)
Most recent open-market transaction: 2026-08-17. As of 2026-08-25.
View full insider trading history → View SEC Form 3/4/5 filingsAsk about BFLY's insider activity →
Only open-market purchases (SEC code P) and sales (code S) are counted here. Option exercises, vesting/awards, gifts, and shares withheld for taxes are excluded — they are compensation or mechanical, not open-market conviction. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan) and are not necessarily bearish; open-market buying is not a recommendation to buy. Informational only — not financial advice.
Institutional ownership (13F)
5 institutional 13F filers reported holding BFLY as of 2026-03-31 (quarter-end position, filed within 45 days).
- Distinct 13F filers 5
- Reported shares held 27,661,460
- Reported value $111,752,297
reported quarterly holdings change (2025-12-31 → 2026-03-31): 0 new, 3 increased, 2 decreased, 0 exited. Change counts cover only managers that filed 13F reports in BOTH quarters, derived between two quarter-end snapshots — not same-day trades; a single manager is never said to have "bought" or "sold".
Institutional holdings are quarter-end long positions reported on SEC Form 13F-HR, filed up to 45 days after the quarter ends — they are delayed, are not real-time trades, exclude short positions and most non-US securities, and are not investment advice. Any increase/decrease is a reported change between two quarterly snapshots, not a same-day purchase or sale. These are quarter-end snapshots from the 13F filings on SEC EDGAR, filed within 45 days — not real-time, and any change is a difference between two quarterly reports, not a same-day trade. Informational only — not financial advice.
Short interest (FINRA)
BFLY had 32,688,557 shares of reported short interest as of the 2026-07-31 FINRA settlement date (delayed, bi-monthly; not real-time).
Short interest as a percent of shares outstanding is not shown for BFLY because we do not hold a verified share count to divide it by. The reported figures above are unaffected.
- Reported short interest (shares) 32,688,557
- Prior settlement (shares) 31,253,468
- Reported change 4.59%
- Days to cover (reported) 4.3
Reported to FINRA as of the 2026-07-31 settlement date. Short interest is reported to FINRA and published on a delayed, bi-monthly schedule (as of a settlement date, disseminated roughly eight business days later) — it is NOT real-time, does not cover every venue or all US trading, and is not a short-squeeze prediction or investment advice. Days-to-cover is the value FINRA reports; percent of float is not shown because the source file carries no share-count denominator — where a percent appears it is of shares OUTSTANDING, the larger base, and is therefore a floor on percent of float. Informational only — not financial advice.
Competitors & peers
- GE HealthCare (GEHC)
- Philips (PHG)
- Siemens Healthineers (SMMNY)
- Fujifilm Sonosite
- Clarius Mobile Health
AI-enriched competitor set. Linked names are companies covered by stocks-llm; other named peers are shown for reference only.
Compare BFLY vs…
BFLY ranks in…
Frequently asked questions
What does BUTTERFLY NETWORK INC CLASS A (BFLY) do?
Butterfly Network is a digital health company focused on transforming medical imaging through its proprietary ultrasound-on-a-chip technology. The company develops and markets handheld, portable ultrasound devices and software platforms that integrate with mobile devices to provide diagnostic imaging capabilities.
What sector is BUTTERFLY NETWORK INC CLASS A (BFLY) in?
BUTTERFLY NETWORK INC CLASS A (BFLY) is classified in the Health Care sector. Its industry is medical devices / diagnostic imaging. It trades on NYSE.
Who are BUTTERFLY NETWORK INC CLASS A's (BFLY) competitors?
Notable peers of BUTTERFLY NETWORK INC CLASS A (BFLY) include GE HealthCare, Philips, Siemens Healthineers, Fujifilm Sonosite and Clarius Mobile Health. This peer set is informational only — not financial advice.
Is BUTTERFLY NETWORK INC CLASS A (BFLY) overbought or oversold right now?
BUTTERFLY NETWORK INC CLASS A (BFLY) is currently neither overbought nor oversold — its 14-day RSI (a 0–100 momentum gauge) is 55, in the neutral middle (as of 2026-08-24). RSI describes recent price momentum, not a forecast — informational only, not financial advice.
Where does stocks-llm's data on BFLY come from?
Fundamentals and prices come from market data, as of 2026-08-24; company filings and profile facts come from SEC EDGAR. All figures are delayed daily-close data shown with their as-of date — informational only, not financial advice.
Fundamentals: market data, as of 2026-08-24. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-08-24.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date.